基础医学与临床 ›› 2014, Vol. 34 ›› Issue (9): 1255-1259.

• 研究论文 • 上一篇    下一篇

大黄素抑制卵巢癌SKOV3细胞增殖和抑制Survivin及XIAP的蛋白表达

孟智超1,李淑玲1,肖建英2   

  1. 1. 辽宁医学院
    2. 辽宁医学院基础医学院
  • 收稿日期:2014-05-12 修回日期:2014-07-09 出版日期:2014-09-05 发布日期:2014-09-02
  • 通讯作者: 肖建英 E-mail:lyxiaojy@163.com

Emodin inhibits human ovarian cancer SKOV3 cells proliferation and the expressions of Survivin and XIAP proteins

  • Received:2014-05-12 Revised:2014-07-09 Online:2014-09-05 Published:2014-09-02

摘要: 目的 观察大黄素对卵巢癌SKOV3细胞的增殖、凋亡和凋亡抑制蛋白Survivin和X染色体连锁凋亡抑制蛋白(XIAP)表达的影响,探讨大黄素对卵巢癌细胞增殖的作用机制。方法 体外培养SKOV3细胞,分对照组(DMSO组)和大黄素组(终浓度为12.5、25和50 μmol/L),MTT法测定SKOV3细胞增殖率;流式细胞术检测细胞凋亡;RT-PCR和Western blot法分别检测SKOV3细胞中Survivin和XIAP mRNA和蛋白表达。结果 与对照组相比,大黄素加药组明显抑制细胞增殖并促进细胞凋亡(P < 0. 01)。大黄素作用后XIAP和Survivin mRNA和蛋白水平较对照组降低(P < 0. 01)。结论 大黄素通过抑制凋亡抑制蛋白Survivin和XIAP表达促进SKOV3细胞凋亡。

关键词: 大黄素, 卵巢癌, SKOV3细胞, 细胞凋亡

Abstract: Objective To investigate the effects of emodin on proliferation and apoptosis of ovarian cancer SKOV3 cells and the expression of Survivin and X-linked inhibitor of apoptosis protein (XIAP)and the possible mechanism. Methods SKOV3 cells were cultured in vitro and divided into control group and emodin groups(final emodin concentration is 12.5, 25 and 50 μmol/L).The SKOV3 cells viability was measured by MTT and the cell apoptosis was determined by flow cytometry analysis. The changes of mRNA and protein were examined by RT-PCR and western blot respectively. Results MTT shows that the proliferation of SKOV3 cells in each group decreased in the different concentration of emodin compared with control group(P < 0. 01); The apoptosis rate of SKOV3 cells increased in the different concentration of emodin groups respectively compared with control group(P < 0. 01). The expression of Survivin and XIAP mRNAs and proteins in SKOV3 cells in the presence of different concentration of emodin decreased compared with control group(P<0.01). Conclusion Emodin could induce apoptosis of ovarian cancer SKOV3 cells by down-regulation of the expressions of Survivin and XIAP proteins.

Key words: emodin, ovarian cancer, SKOV3, apoptosis